Evidence map›Paper›PMID 34355424›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2021

Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies.

Carlos R Ferreira, Kristina Kintzinger, Mary E Hackbarth, Ulrike Botschen, Yvonne Nitschke, M Zulf Mughal, Genevieve Baujat, Dirk Schnabel, Eric Yuen, William A Gahl and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Peripheral Vascular Calcification.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  7. Article
  8. Article
  9. Six cases ofJBMR plus · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Carlos R FerreiraNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2697-1046
Kristina KintzingerDepartment of General Pediatrics, Münster University Children's Hospital, Münster, Germany.
Mary E HackbarthNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Ulrike BotschenDepartment of General Pediatrics, Münster University Children's Hospital, Münster, Germany.
Yvonne NitschkeDepartment of General Pediatrics, Münster University Children's Hospital, Münster, Germany.
M Zulf MughalDepartment of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK.
Genevieve BaujatCentre de Référence Maladies Osseuses Constitutionnelles (CR MOC) et Filière OSCAR, Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France.
Dirk SchnabelCenter for Chronically Sick Children, Pediatric Endocrinology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Eric YuenInozyme Pharma, Inc., Boston, MA, USA.
William A GahlNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Rachel I GafniNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Qing LiuQuantitative & Regulatory Medical Science, LLC, Long Valley, NJ, USA.
Pedro HuertasInozyme Pharma, Inc., Boston, MA, USA.
Gus KhursigaraInozyme Pharma, Inc., Boston, MA, USA.
Frank RutschDepartment of General Pediatrics, Münster University Children's Hospital, Münster, Germany.
National Institutes of Health · USUniversity Hospital Münster · DECharité - Universitätsmedizin Berlin · DEHôpital Necker-Enfants Malades · FRRoyal Manchester Children's Hospital · GB

Funding

Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
Skeletal GenomicsZIAHG200407 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI FERREIRA, CARLOS · 2020 to 2024
$3.7M
Intramural NIH HHS ZIA HG200407NHGRI NIH HHSNIDCR NIH HHS
6 · The paper itself

Abstract

Generalized arterial calcification of infancy (GACI) is a rare disorder caused by ENPP1 or ABCC6 variants. GACI is characterized by low pyrophosphate, arterial calcification, and high mortality during the first year of life, but the natural course and possible differences between the causative genes remain unknown. In all, 247 individual records for patients with GACI (from birth to 58.3 years of age) across 19 countries were reviewed. Overall mortality was 54.7% (13.4% in utero or stillborn), with a 50.4% probability of death before the age of 6 months (critical period). Contrary to previous publications, we found that bisphosphonate treatment had no survival benefit based on a start-time matched analysis and inconclusive results when initiated within 2 weeks of birth. Despite a similar prevalence of GACI phenotypes between ENPP1 and ABCC6 deficiencies, including arterial calcification (77.2% and 89.5%, respectively), organ calcification (65.8% and 84.2%, respectively), and cardiovascular complications (58.4% and 78.9%, respectively), mortality was higher for ENPP1 versus ABCC6 variants (40.5% versus 10.5%, respectively; p = 0.0157). Higher prevalence of rickets was reported in 70.8% of surviving affected individuals with ENPP1 compared with that of ABCC6 (11.8%; p = 0.0001). Eleven affected individuals presenting with rickets and without a GACI diagnosis, termed autosomal recessive hypophosphatemic rickets type 2 (ARHR2), all had confirmed ENPP1 variants. Approximately 70% of these patients demonstrated evidence of ectopic calcification or complications similar to those seen in individuals with GACI, which shows that ARHR2 is not a distinct condition from GACI but represents part of the spectrum of ENPP1 deficiency. Overall, this study identified an early mortality risk in GACI patients despite attempts to treat with bisphosphonates, high prevalence of rickets almost exclusive to ENPP1 deficiency, and a spectrum of heterogenous calcification and multiple organ complications with both ENPP1 and ABCC6 variants, which suggests an overlapping pathology. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Indexed as

ATP-Binding Cassette, Sub-Family C ProteinsFamilial Hypophosphatemic RicketsPhosphoric Diester HydrolasesPyrophosphatasesVascular CalcificationHumansInfantMutationABCC6 protein, humanATP-Binding Cassette, Sub-Family C Proteinsectonucleotide pyrophosphatase phosphodiesterase 1Phosphoric Diester HydrolasesPyrophosphatasesABCC6 deficiencydiseases and disorders of/ related to boneectopic calcificationENPP1 deficiencyGeneralized Arterial Calcification of Infancyhypophosphatemic ricketsnatural history studyosteomalaciaricketssurvival analysis

Identifiers

PMID34355424
PMCPMC8595532
OpenAlexW3193080514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.